Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene—a gene that can cause cancer—that may ...

They also found that after the extra chromosome was removed, genes tied to nervous system development were more active and ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

I n a world first, scientists have created mice with two fathers, capable of having offspring of their own. It’s a huge step ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

In a global first for Africa, UCT is participating in a clinical trial to reprogramme genes and halt hereditary angioedema.

Researchers have identified a mutation in a common oncogene that may play an important role in colon cancer. Their findings ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role ...